Waters Corporation shares have fallen to $357.08 over the last six months, a 7.2% decline that contrasts with the S&P 500's 7.8% gain. The company's five-year annualized revenue growth of 8.5% slightly outpaced the average healthcare company, and its five-year average return on invested capital of 30.5% ranks among the best in the sector. However, organic revenue growth averaged just 4.9% over the past two years, lagging the sector and suggesting waning demand in its core business. The stock now trades at 23.9 times forward earnings.
Waters CorporationOrganic revenue growth averaged just 4.9% over the past two years, lagging the sector and suggesting waning demand in its core business.